Benzinga | Jun 22, 2021 10:59AM EDT

BioCryst Pharmaceuticals Granted U.S. Patent Titled 'Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies (APeX-A)'

https://clinicaltrials.gov/ct2/show/NCT04933721